fenspiride has been researched along with Bronchitis, Chronic in 3 studies
fenspiride: was heading 1975-94 (see under SPIRO COMPOUNDS 1975-90); use SPIRO COMPOUNDS to search FENSPIRIDE 1975-94; bronchodilator agent used in asthma
Bronchitis, Chronic: A subcategory of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. The disease is characterized by hypersecretion of mucus accompanied by a chronic (more than 3 months in 2 consecutive years) productive cough. Infectious agents are a major cause of chronic bronchitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Quality and quantity of sputum and cough significantly improved in the fenspiride group (comparing to the placebo group p= 0." | 9.11 | [The effect of fenspiride on the number of exacerbations and the time of first exacerbation in patients with chronic bronchitis]. ( Bartmińiski, W; Chyczewska, E; Malinowski, J; Nowak, D; Pachocki, R; Pirozyński, M; Skucha, W; Słomiński, M, 2005) |
| "PATHOPHYSIOLOGY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): Chronic inflammation of the upper airways, pulmonary parenchyma and pulmonary vasculature is the characteristic feature of COPD." | 5.31 | [Bronchial inflammation during chronic bronchitis, importance of fenspiride]. ( Melloni, B, 2002) |
| "Quality and quantity of sputum and cough significantly improved in the fenspiride group (comparing to the placebo group p= 0." | 5.11 | [The effect of fenspiride on the number of exacerbations and the time of first exacerbation in patients with chronic bronchitis]. ( Bartmińiski, W; Chyczewska, E; Malinowski, J; Nowak, D; Pachocki, R; Pirozyński, M; Skucha, W; Słomiński, M, 2005) |
| "Fenspiride is an effective drug for the treatment of moderate chronic obstructive bronchitis." | 2.70 | [Effectiveness of fenspiride in patients with chronic obstructive bronchitis]. ( Gracheva, EIu; Iusupova, RS; Lapik, SV; Medvedeva, IV; Shorokhova, TD; Solov'eva, OG, 2001) |
| "PATHOPHYSIOLOGY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): Chronic inflammation of the upper airways, pulmonary parenchyma and pulmonary vasculature is the characteristic feature of COPD." | 1.31 | [Bronchial inflammation during chronic bronchitis, importance of fenspiride]. ( Melloni, B, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Melloni, B | 1 |
| Pirozyński, M | 1 |
| Skucha, W | 1 |
| Słomiński, M | 1 |
| Chyczewska, E | 1 |
| Malinowski, J | 1 |
| Nowak, D | 1 |
| Bartmińiski, W | 1 |
| Pachocki, R | 1 |
| Shorokhova, TD | 1 |
| Medvedeva, IV | 1 |
| Lapik, SV | 1 |
| Solov'eva, OG | 1 |
| Gracheva, EIu | 1 |
| Iusupova, RS | 1 |
2 trials available for fenspiride and Bronchitis, Chronic
| Article | Year |
|---|---|
[The effect of fenspiride on the number of exacerbations and the time of first exacerbation in patients with chronic bronchitis].
Topics: Adult; Aged; Bronchial Spasm; Bronchitis, Chronic; Cough; Dyspnea; Expectorants; Female; Humans; Mal | 2005 |
[Effectiveness of fenspiride in patients with chronic obstructive bronchitis].
Topics: Adult; Bronchitis, Chronic; Bronchodilator Agents; Forced Expiratory Volume; Humans; Lipid Peroxidat | 2001 |
1 other study available for fenspiride and Bronchitis, Chronic
| Article | Year |
|---|---|
[Bronchial inflammation during chronic bronchitis, importance of fenspiride].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchitis, Chronic; Bronchoconstriction; Clinical | 2002 |